Skip to main content
Drug bottle and Pill

Compare Tezspire vs. Dupixent

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Tezspire (tezepelumab) and Dupixent (dupilumab) are both injectable biologic medications used to treat asthma, but they belong to different medication classes. Tezspire is a thymic stromal lymphopoietin (TSLP) blocker, while Dupixent is an interleukin antagonist. Tezspire is specifically approved for severe asthma in people aged 12 and older, whereas Dupixent is approved for moderate-to-severe asthma in people aged 6 and older, as well as other conditions like eczema and eosinophilic esophagitis. Tezspire is typically injected once a month by a healthcare professional, while Dupixent is usually injected every 1 to 4 weeks, depending on the condition being treated. Both medications are available as pre-filled pens and syringes. Tezspire has a low risk of side effects but can cause joint and back pain, while Dupixent can cause injection site reactions and eye inflammation. Both medications can cause serious allergic reactions and are not used to treat asthma attacks.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.